Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00074841 | Trial of Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine for the Treatment of Uncomplicated Malaria in India | PHASE2 | COMPLETED | 230 | — | — | Sep 1, 2003 | Jan 1, 2005 | May 10, 2011 | 7 | India |
| Name | Type | Description |
|---|---|---|
| Azithromycin/Chloroquine | DRUG | - |
| Sulfadoxine-Pyrimethamine/Chloroquine | DRUG | - |
INCLUSION CRITERIA: * Females and males \>=18 years of age with uncomplicated, symptomatic malaria as indicated by the presence of both of the following: a.) Blood smears positive for Plasmodium falciparum asexual parasitemia between 1000 -100,000 parasites/uL; b.) Fever or history of fever ( \>=38...